Bone Marrow Erythroid Precursor Ca++ Regulates the Response to Human Recombinant Erythropoietin (Rhuepo) in Hemodialysis Patients

Autor: Caviglia Pm, Ramello A, Schelotto C, Salit M, Silvia Carozzi, Cantaluppi A, M. G. Nasini, Silvano Lamperi
Rok vydání: 1990
Předmět:
Zdroj: The International Journal of Artificial Organs. 13:747-750
ISSN: 1724-6040
0391-3988
DOI: 10.1177/039139889001301107
Popis: The modulation of erythropoiesis by erythropoietin is conditioned by the concentration of Ca++ in the cytoplasm of the bone marrow erythroid precursors. We evaluated in vitro erythroid colony development from bone marrow erythroid precursors incubated with increasing concentrations of Ca++ or Ca++ plus 1,25 (OH)2 D3, and bone marrow erythroid precursor cytoplasmic Ca++ concentrations in 10 anemic hemodialysis (HD) patients before and during rHuEPO therapy. Results showed that: a) in vitro: in uremics patients before rHuEPO therapy, bone marrow erythroid precursor cytoplasmic Ca++ was lower than in normal subjects; the addition of Ca++ to the bone marrow erythroid precursors induced a dose-dependent Ca++ and erythroid colony development increase; 1,25 (OH)2 D3 potentiated this effect; b) in vivo: rHuEPO normalized bone marrow erythroid precursor Ca++ and erythroid colony development. An inverse correlation was seen between bone marrow erythroid colony development, precursor CA++ before therapy, the in vitro erythroid and the rHuEPO dose needed in vivo to normalize hematological parameters. These data emphasize the role of Ca++ in erythropoiesis and may aid understanding of the mode of action of rHuEPO in HD.
Databáze: OpenAIRE